Case report: A kidney transplant patient with mild COVID-19.
Emre ArpaliBasak AkyolluBerna YelkenSuda TekinAydin TurkmenBurak KocakPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
Coronavirus Disease 2019 (COVID-19) is currently a pandemic with a mortality rate of 1%-6% in the general population. However, the mortality rate seems to be significantly higher in elderly patients, especially those hospitalized with comorbidities, such as hypertension, diabetes, or coronary artery diseases. Because viral diseases may have atypical presentations in immunosuppressed patients, the course of the disease in the transplant patient population is unknown. Hence, the management of these patients with COVID-19 is an area of interest, and a unique approach is warranted. Here, we report the clinical features and our treatment approach for a kidney transplant patient with a diagnosis of COVID-19. We believe that screening protocols for SARS-Cov-2 should be re-evaluated in patients with solid-organ transplants.
Keyphrases
- sars cov
- coronavirus disease
- case report
- respiratory syndrome coronavirus
- coronary artery
- end stage renal disease
- cardiovascular disease
- ejection fraction
- type diabetes
- blood pressure
- cardiovascular events
- risk factors
- pulmonary artery
- skeletal muscle
- pulmonary hypertension
- metabolic syndrome
- coronary artery disease
- glycemic control
- patient reported
- replacement therapy